Activation/NN
and/CC
expression/NN
of/IN
the/DT
nuclear/JJ
factors/NNS
of/IN
activated/VBN
T/NN
cells/NNS
,/,
NFATp/NN
and/CC
NFATc/NN
,/,
in/IN
human/JJ
natural/JJ
killer/NN
cells/NNS
:/:
regulation/NN
upon/IN
CD16/NN
ligand/NN
binding/NN
./.

The/DT
putative/JJ
factors/NNS
that/WDT
couple/VBP
the/DT
signal/NN
transduction/NN
from/IN
surface/NN
receptors/NNS
to/TO
the/DT
activation/NN
of/IN
cytokine/NN
synthesis/NN
in/IN
natural/JJ
killer/NN
(/(
NK/NN
)/)
cells/NNS
have/VBP
not/RB
been/VBN
elucidated/VBN
./.
=====
We/PRP
report/VBP
here/RB
that/IN
the/DT
nuclear/JJ
factor/NN
of/IN
activated/VBN
T/NN
cells/NNS
(/(
NFATp/NN
)/)
,/,
a/DT
cyclosporin/NN
A/NN
(/(
CsA/NN
)/)
-sensitive/JJ
factor/NN
that/WDT
regulates/VBZ
the/DT
transcription/NN
of/IN
several/JJ
cytokines/NNS
,/,
mediates/VBZ
CD16-induced/JJ
activation/NN
of/IN
cytokine/NN
genes/NNS
in/IN
human/JJ
NK/NN
cells/NNS
./.
=====
CD16/NN
(/(
Fc/NN
gamma/NN
RIIIA/NN
)/)
-induced/JJ
expression/NN
of/IN
cytokine/NN
mRNA/NN
in/IN
NK/NN
cells/NNS
occurs/VBZ
via/IN
a/DT
CsA-sensitive/JJ
and/CC
Ca(2+)-dependent/JJ
mechanism/NN
./.
=====
Stimulation/NN
of/IN
NK/NN
cells/NNS
with/IN
CD16/NN
ligands/NNS
induces/VBZ
NFAT-like/JJ
DNA/NN
binding/NN
activity/NN
in/IN
the/DT
nuclear/JJ
extracts/NNS
from/IN
these/DT
cells/NNS
,/,
as/IN
detected/VBN
in/IN
electrophoretic/JJ
mobility/NN
shift/NN
assays/NNS
./.
=====
This/DT
occurs/VBZ
with/IN
fast/JJ
kinetics/NNS
after/IN
stimulation/NN
,/,
via/IN
a/DT
CsA-sensitive/JJ
and/CC
Ca(2+)-dependent/JJ
mechanism/NN
that/WDT
does/VBZ
not/RB
require/VB
de/FW
novo/FW
protein/NN
synthesis/NN
./.
=====
NK/NN
cell/NN
NFAT/NN
is/VBZ
present/JJ
in/IN
the/DT
cytosol/NN
of/IN
nonstimulated/JJ
cells/NNS
,/,
migrates/VBZ
to/TO
the/DT
nucleus/NN
upon/IN
stimulation/NN
,/,
and/CC
can/MD
associate/VB
with/IN
AP-1/NN
./.
=====
Two/CD
distinct/JJ
molecules/NNS
,/,
NFATp/NN
and/CC
NFATc/NN
,/,
have/VBP
been/VBN
reported/VBN
to/TO
mediate/VB
NFAT/NN
activity/NN
./.
=====
The/DT
results/NNS
of/IN
supershift/NN
assays/NNS
using/VBG
NFATp-/NN
and/CC
NFATc-specific/JJ
antibodies/NNS
indicate/VBP
that/IN
NK/NN
cell/NN
activation/NN
early/RB
after/IN
CD16/NN
ligand/NN
binding/NN
involves/VBZ
primarily/RB
,/,
if/IN
not/RB
exclusively/RB
,/,
NFATp/NN
,/,
and/CC
Western/NN
blot/NN
analysis/NN
shows/VBZ
that/IN
this/DT
has/VBZ
the/DT
same/JJ
electrophoretic/JJ
mobility/NN
(/(
approximately/RB
120/CD
kD/NN
)/)
as/IN
that/DT
of/IN
T/NN
lymphocytes/NNS
./.
=====
NK/NN
cells/NNS
do/VBP
not/RB
express/VB
NFATc/NN
constitutively/RB
,/,
but/CC
NFATc/NN
mRNA/NN
accumulation/NN
is/VBZ
induced/VBN
in/IN
these/DT
cells/NNS
within/IN
2/CD
h/NN
of/IN
stimulation/NN
with/IN
CD16/NN
ligands/NNS
./.
=====
However/RB
,/,
supershift/NN
assays/NNS
using/VBG
the/DT
available/JJ
mAb/NN
recognizing/VBG
the/DT
T/NN
cell/NN
NFATc/NN
revealed/VBD
no/DT
detectable/JJ
NFATc/NN
protein/NN
in/IN
nuclear/JJ
and/CC
cytoplasmic/JJ
extracts/NNS
from/IN
CD16-/NN
or/CC
phorbol/NN
ester-stimulated/JJ
cells/NNS
at/IN
any/DT
time/NN
tested/VBN
,/,
up/RB
to/TO
4/CD
h/NN
./.
=====
These/DT
results/NNS
provide/VBP
the/DT
first/JJ
direct/JJ
evidence/NN
that/IN
both/DT
CsA-sensitive/JJ
transcription/NN
factors/NNS
,/,
NFATp/NN
and/CC
NFATc/NN
,/,
are/VBP
expressed/VBN
in/IN
human/JJ
NK/NN
cells/NNS
,/,
and/CC
that/IN
their/PRP$
activation/NN
and/or/CC
expression/NN
can/MD
be/VB
regulated/VBN
in/IN
primary/JJ
cells/NNS
by/IN
a/DT
single/JJ
stimulus/NN
,/,
that/WDT
,/,
in/IN
the/DT
case/NN
of/IN
CD16/NN
in/IN
NK/NN
cells/NNS
,/,
results/VBZ
in/IN
early/JJ
activation/NN
of/IN
NFATp/NN
and/CC
subsequently/RB
induced/VBN
expression/NN
of/IN
NFATc/NN
mRNA/NN
./.